George S. Barrett Sells 217,995 Shares of Cardinal Health Inc. (CAH) Stock
Cardinal Health Inc. (NYSE:CAH) Chairman George S. Barrett sold 217,995 shares of the firm’s stock in a transaction dated Thursday, November 10th. The shares were sold at an average price of $71.29, for a total transaction of $15,540,863.55. Following the completion of the sale, the chairman now owns 682,226 shares of the company’s stock, valued at $48,635,891.54. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink.
Shares of Cardinal Health Inc. (NYSE:CAH) opened at 71.39 on Wednesday. The firm’s 50 day moving average is $73.51 and its 200-day moving average is $78.18. The company has a market cap of $22.85 billion, a PE ratio of 17.28 and a beta of 0.73. Cardinal Health Inc. has a 1-year low of $62.70 and a 1-year high of $91.23.
Cardinal Health (NYSE:CAH) last released its earnings results on Monday, October 31st. The company reported $1.24 earnings per share for the quarter, beating the Zacks’ consensus estimate of $1.21 by $0.03. The firm had revenue of $32 billion for the quarter, compared to analysts’ expectations of $31.12 billion. Cardinal Health had a net margin of 1.08% and a return on equity of 25.20%. The company’s quarterly revenue was up 14.2% on a year-over-year basis. During the same period in the previous year, the company earned $1.38 earnings per share. Equities analysts expect that Cardinal Health Inc. will post $5.47 earnings per share for the current year.
The business also recently announced a quarterly dividend, which will be paid on Sunday, January 15th. Shareholders of record on Tuesday, January 3rd will be paid a $0.4489 dividend. This represents a $1.80 dividend on an annualized basis and a yield of 2.52%. The ex-dividend date of this dividend is Thursday, December 29th. Cardinal Health’s payout ratio is 43.58%.
CAH has been the subject of several research reports. Citigroup Inc. raised their price objective on shares of Cardinal Health from $87.00 to $93.00 and gave the stock a “neutral” rating in a research report on Wednesday, August 3rd. Leerink Swann restated a “buy” rating on shares of Cardinal Health in a research report on Wednesday, August 3rd. Deutsche Bank AG raised their price objective on shares of Cardinal Health from $83.00 to $89.00 and gave the stock a “hold” rating in a research report on Thursday, August 4th. Zacks Investment Research upgraded shares of Cardinal Health from a “sell” rating to a “hold” rating in a research report on Monday, August 8th. Finally, Credit Suisse Group AG restated a “buy” rating and set a $97.00 price objective on shares of Cardinal Health in a research report on Tuesday, August 30th. Ten investment analysts have rated the stock with a hold rating, seven have issued a buy rating and one has assigned a strong buy rating to the company. The stock presently has an average rating of “Buy” and an average price target of $91.62.
Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Charlemagne Capital Ltd. boosted its position in Cardinal Health by 0.4% in the second quarter. Charlemagne Capital Ltd. now owns 2,527 shares of the company’s stock worth $196,000 after buying an additional 10 shares during the last quarter. Alpha Windward LLC boosted its stake in shares of Cardinal Health by 0.8% in the third quarter. Alpha Windward LLC now owns 2,133 shares of the company’s stock worth $166,000 after buying an additional 16 shares during the last quarter. KCM Investment Advisors LLC boosted its stake in shares of Cardinal Health by 0.3% in the third quarter. KCM Investment Advisors LLC now owns 5,778 shares of the company’s stock worth $449,000 after buying an additional 17 shares during the last quarter. Bridgewater Wealth & Financial Management LLC boosted its stake in shares of Cardinal Health by 0.3% in the second quarter. Bridgewater Wealth & Financial Management LLC now owns 6,561 shares of the company’s stock worth $512,000 after buying an additional 19 shares during the last quarter. Finally, Conning Inc. boosted its stake in shares of Cardinal Health by 0.3% in the second quarter. Conning Inc. now owns 7,980 shares of the company’s stock worth $623,000 after buying an additional 20 shares during the last quarter. Hedge funds and other institutional investors own 88.19% of the company’s stock.
About Cardinal Health
Cardinal Health, Inc is a healthcare services and products company. The Company operates through two segments: Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, over-the-counter healthcare and consumer products. This segment also operates nuclear pharmacies and cyclotron facilities; provides pharmacy management services to hospitals, as well as medication therapy management and patient outcomes services to hospitals, other healthcare providers and payers, and provides services to healthcare companies.
Receive News & Stock Ratings for Cardinal Health Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health Inc. and related stocks with our FREE daily email newsletter.